Total planned funding: $1,316,760,911
Clear active filters
Chemonics International
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Tanzania | $237,205,430 |
Nigeria | $231,940,171 |
Zambia | $222,755,303 |
Mozambique | $112,780,214 |
Kenya | $85,738,240 |
Uganda | $70,165,274 |
Zimbabwe | $65,138,821 |
Rwanda | $63,336,629 |
Haiti | $38,305,300 |
Democratic Republic of the Congo | $35,349,642 |
Ethiopia | $34,912,214 |
Vietnam | $22,818,809 |
Côte d'Ivoire | $20,569,437 |
Ukraine | $15,819,470 |
Eswatini | $12,287,764 |
South Africa | $12,034,196 |
South Sudan | $4,836,366 |
Burundi | $4,169,218 |
Malawi | $3,496,468 |
Cameroon | $3,471,305 |
Lesotho | $3,000,000 |
Ghana | $2,760,959 |
Angola | $2,517,189 |
Namibia | $2,260,800 |
Indonesia | $2,200,001 |
Botswana | $1,867,945 |
Caribbean Region | $1,746,596 |
Central America Region | $1,487,150 |
Burma | $1,050,000 |
Cambodia | $490,000 |
Central Asia Region | $250,000 |
Organizational Types
Private Contractor | $1,316,760,911 |
Program Areas
Treatment | $1,010,159,877 |
Care | $96,349,481 |
Testing | $73,758,828 |
Governance and Systems | $69,746,308 |
Prevention | $66,746,417 |
Budget Codes
HTXD: Treatment: ARV Drugs | $754,649,543 |
HTXS: Treatment: Adult Treatment | $235,321,138 |
HVCT: Testing: HIV Testing and Counseling | $73,758,828 |
HBHC: Care: Adult Care and Support | $61,837,647 |
OHSS: Health Systems Strengthening | $56,311,899 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $25,769,213 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $22,887,923 |
PDTX: Treatment: Pediatric Treatment | $20,189,196 |
HVTB: Care: TB/HIV | $18,048,797 |
HVOP: Sexual Prevention: Other Sexual Prevention | $14,031,412 |
HLAB: Laboratory Infrastructure | $11,106,632 |
HKID: Care: Orphans and Vulnerable Children | $8,794,927 |
PDCS: Care: Pediatric Care and Support | $7,668,110 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,374,215 |
HVSI: Strategic Information | $2,327,777 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $781,000 |
HMBL: Biomedical Prevention: Blood Safety | $474,023 |
HMIN: Biomedical Prevention: Injection Safety | $428,631 |
Top Partner Programs
Chemonics International:
$1,316,760,911
View countries